Anya Biopharm Secures Positive Phase I Data for Oral Peptide Weight-Loss Candidate ANY004, Overcoming Low Oral Absorption Barriers｜Institute for Biotechnology and Medicine Industry│IBMI
PR
By Priya Raman · Science Reporter
Nov 7 03:00 ETSource: 全球醫療採購網
From the source
Read at ibmi.taiwan-healthcare.orgAnya Biopharm Secures Positive Phase I Data for Oral Peptide Weight-Loss Candidate ANY004, Overcoming Low Oral Absorption Barriers｜Institute for Biotechnology and Medicine Industry│IBMI
